{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T20:08:08Z","timestamp":1789848488532,"version":"4.0.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016724","name":"Postgraduate Institute of Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016724","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.htct.2026.106538","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:15:32Z","timestamp":1789737332000},"page":"106538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of low- and high-dose apheresis platelets in platelet-refractory patients with hematologic malignancies"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6781-6148","authenticated-orcid":false,"given":"Suvetha","family":"Rajendran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ratti Ram","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rekha","family":"Hans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0961-0369","authenticated-orcid":false,"given":"Divjot Sing","family":"Lamba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9585","key":"10.1016\/j.htct.2026.106538_bib0001","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(07)61198-2","article-title":"Platelet transfusions","volume":"370","author":"Stroncek","year":"2007","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.htct.2026.106538_bib0002","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.tracli.2022.11.007","article-title":"The appropriateness of platelet transfusions in hematological patients and the potential for improvement","volume":"30","author":"Liker","year":"2023","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.htct.2026.106538_bib0003","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2147\/JBM.S234374","article-title":"Platelet transfusion: and update on challenges and outcomes","volume":"11","author":"Solves Alcaina","year":"2020","journal-title":"J Blood Med"},{"issue":"5","key":"10.1016\/j.htct.2026.106538_bib0004","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humimm.2020.02.005","article-title":"Diagnosis and treatment of immunological platelet refractoriness by histocompatibility","volume":"81","author":"Fagundes","year":"2020","journal-title":"Hum Immunol"},{"issue":"4","key":"10.1016\/j.htct.2026.106538_bib0005","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s002770050280","article-title":"Frequency and causes of refractoriness in multiply transfused patients","volume":"74","author":"Legler","year":"1997","journal-title":"Ann Hematol"},{"key":"10.1016\/j.htct.2026.106538_bib0006","article-title":"Current status of and global trends in platelet transfusion refractoriness from 2004 to 2021: a bibliometric analysis","volume":"9","author":"Liu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.htct.2026.106538_bib0007","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0973-6247.150953","article-title":"Prevalence of risk factors forplatelet transfusion refractoriness in multitransfused patients with hematologic malignancies attertiary care center in North India","volume":"9","author":"Kumawat","year":"2015","journal-title":"Asian J Transfus Sci"},{"key":"10.1016\/j.htct.2026.106538_bib0008","series-title":"Transfusion medicine: technical manual. Directorate general of health services, ministry of health and family welfare","author":"Saran","year":"2003"},{"issue":"6","key":"10.1016\/j.htct.2026.106538_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.09.010","article-title":"Efficacy of cross-match compatible platelets in multi transfused haemato-oncology patients refractory to platelet transfusion","volume":"58","author":"Chavan","year":"2019","journal-title":"Transfus Apher Sci"},{"issue":"2","key":"10.1016\/j.htct.2026.106538_bib0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4103\/GJTM.GJTM_51_19","article-title":"Platelet compatibility and platelet antibodies detection: a step towards resolving dilemma in management of platelet refractoriness in oncology patients","volume":"4","author":"Mangwana","year":"2019","journal-title":"Glob J Transfus Med"},{"key":"10.1016\/j.htct.2026.106538_bib0011","first-page":"134","article-title":"Platelet alloimmunization in multitransfused patients with haemato-oncologicaldisorders","volume":"18","author":"Bajpai","year":"2005","journal-title":"Natl Med J India"},{"issue":"1","key":"10.1016\/j.htct.2026.106538_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2019.06.033","article-title":"Comparison of efficacy of low and high-dose prophylactic platelet transfusion therapy in thrombocytopenic haemato-oncology patients","volume":"59","author":"Dhiman","year":"2020","journal-title":"Transfus Apher Sci"},{"issue":"7","key":"10.1016\/j.htct.2026.106538_bib0013","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.htct.2026.106538_bib0014","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddle","year":"2009","journal-title":"Blood"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002853?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137926002853?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T19:51:11Z","timestamp":1789847471000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137926002853"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2531137926002853"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2026.106538","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative analysis of low- and high-dose apheresis platelets in platelet-refractory patients with hematologic malignancies","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2026.106538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"106538"}}